CPT 88319Laboratory

Enzyme histochemistry

CPT 88319 covers enzyme histochemistry testing, a specialized laboratory technique that uses chemical reactions to identify specific enzymes in tissue samples under a microscope. This helps pathologists diagnose muscle diseases, metabolic disorders, and certain types of cancer by revealing enzyme patterns that aren't visible with standard staining methods.

Showing rates for

National Average

Base Medicare rate

$131.33

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

0.53

PE RVU (NF)

3.5

MP RVU

0.03

Total RVU

4.06

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Document the specific enzyme(s) tested and clinical indication in the pathology report, as generic descriptions like 'special stains ordered' will trigger denials
Impact: Prevents an estimated 30-40% of medical necessity denials and supports the full $131.33 reimbursement
Bill 88319 per each enzyme studied, not per tissue block or slide, and clearly itemize each enzyme in supporting documentation
Impact: Ensures accurate unit billing; testing 3 different enzymes allows billing 3 units at $131.33 each ($393.99 total)
Verify that fresh frozen tissue requirements were met and documented, as some payers deny claims when enzyme studies are attempted on improperly preserved specimens
Impact: Eliminates technical denials that can delay payment by 30-60 days and require reprocessing
Link to appropriate ICD-10 codes indicating neuromuscular disorder, metabolic myopathy, or mitochondrial disease suspicion rather than generic signs/symptoms
Impact: Increases first-pass acceptance rate by 25-35% versus billing with non-specific symptom codes
When billing with surgical pathology codes (88302-88309), ensure 88319 is billed as a separate line item with modifier 59 if necessary to bypass NCCI edits
Impact: Prevents automatic bundling that would result in loss of the $131.33 enzyme histochemistry payment
Establish and document medical necessity by including prior non-diagnostic test results or clinical findings that specifically warrant enzyme studies
Impact: Creates audit-proof documentation trail supporting medical necessity for services with 4.06 total RVUs

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88319?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT 88319 in 2025?

The 2025 Medicare national average reimbursement rate for CPT 88319 is $131.33 for both facility and non-facility settings. This is based on 4.06 total RVUs (0.53 work RVU, 3.5 practice expense RVU, 0.03 malpractice RVU) multiplied by the 2025 conversion factor of 32.3465.

How many times can you bill CPT 88319 for the same specimen?

You can bill 88319 multiple times (multiple units) for the same specimen when different enzymes are tested, as billing is per enzyme studied, not per specimen or block. Documentation must clearly identify each distinct enzyme tested and the clinical necessity for each. Some payers may have coverage limitations requiring modifier 91 for same-day repeat testing.

What is the difference between CPT 88319 and 88342 immunohistochemistry?

CPT 88319 (enzyme histochemistry) detects enzyme activity through chemical substrate reactions, while 88342 (immunohistochemistry) uses antibodies to detect specific proteins or antigens. Enzyme histochemistry is primarily used for metabolic and mitochondrial disorders, particularly in muscle biopsies, while immunohistochemistry is more commonly used for tumor classification and infectious disease diagnosis. They use different techniques and reagents and should not be billed together for the same marker.

Is CPT 88319 an add-on code or standalone code?

CPT 88319 is a standalone code, not an add-on code, though it is typically billed in conjunction with surgical pathology examination codes (88302-88309). It can be billed independently and does not require a primary procedure code, but clinical context usually involves tissue examination where enzyme studies supplement routine pathology evaluation.

What diagnoses support medical necessity for CPT 88319?

Medical necessity for 88319 is typically supported by ICD-10 codes indicating suspected or confirmed neuromuscular disorders including metabolic myopathies (G71.0-G71.3), mitochondrial myopathies (G71.3), glycogen storage diseases (E74.0x), lipid storage disorders (E75.x), muscular dystrophies (G71.0), and unexplained muscle weakness or enzyme elevations (M62.81, R73.0). Documentation should explain why enzyme studies are necessary for differential diagnosis.

Do you need modifier 26 or TC when billing CPT 88319?

Modifier 26 (professional component) or TC (technical component) should be used when the service is split between facilities. Independent pathologists billing only for interpretation use modifier 26, while hospital laboratories performing the technical work use modifier TC. If the same entity performs both components, bill 88319 without a modifier for the global service receiving the full $131.33 reimbursement.

What are common reasons for CPT 88319 claim denials?

Common denial reasons include insufficient documentation of medical necessity, lack of specific enzyme identification in pathology reports, incorrect bundling with surgical pathology codes without modifier 59, duplicate service edits when multiple enzymes are tested, specimen preservation issues, and billing with non-specific diagnosis codes. Appealing requires detailed documentation showing specific enzymes tested, clinical indication, and results.